A multinational observational study identifying primary care patients at risk of overestimation of asthma control

Author:

Kritikos Vicky,Price DavidORCID,Papi Alberto,Infantino Antonio,Ställberg Bjorn,Ryan DermotORCID,Lavorini FedericoORCID,Chrystyn Henry,Haughney JohnORCID,Lisspers Karin,Gruffydd-Jones Kevin,Román Rodríguez Miguel,Høegh Henrichsen Svein,van der Molen Thys,Carter VictoriaORCID,Bosnic-Anticevich Sinthia

Abstract

AbstractFactors related to the discrepancy between patient-perceived and actual disease control remain unclear. Identifying patients at risk of overestimation of asthma control remains elusive. This study aimed to (i) investigate the relationship between patient-reported and actual level of asthma control (ii), compare the characteristics between patients who believe their asthma is well controlled that accurately report ‘well-controlled’ asthma with those that do not, and (iii) identify factors associated with inaccurately reported ‘well-controlled’ asthma. A historical, multinational, cross-sectional study using data from the iHARP (initiative Helping Asthma in Real-life Patients) review service for adults with asthma prescribed fixed-dose combination therapy. Data from 4274 patients were analysed. A major discrepancy between patient-reported and Global Initiative for Asthma defined asthma control was detected; 71.1% of patients who reported ‘well-controlled’ asthma were inaccurate in their perception despite receiving regular maintenance therapy. Significant differences were noted in age, gender, body mass index, education level, medication use, side effects, attitudes to preventer inhaler use, inhaler technique review and respiratory specialist review between patients who accurately reported ‘well-controlled’ asthma and those who did not. Independent risk factors associated with inaccurately reported ‘well-controlled’ asthma were: having taken a maximum of 5–12 puffs or more of reliever inhaler on at least one day within the previous 4 weeks; being female; having seen a respiratory specialist more than a year ago (rather than in the previous year); and having required oral corticosteroids for worsening asthma in the previous year. The study highlighted the significant hidden burden associated with under-recognition of poor asthma control, on the part of the patient and the need for targeted interventions designed to address the continuing discrepancy between perceived and actual disease control.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine

Reference55 articles.

1. Global Asthma Network (GAN). The Global Asthma Report (2018). www.globalasthmareport.org/Global%20Asthma%20Report%202018.pdf.

2. European Lung white book (2018). www.erswhitebook.org/chapters.

3. Global Initiative for Asthma. Pocket Guide for Asthma Management and Prevention (2018). www.ginasthma.org/2018-pocket-guide-for-asthma-management-and-prevention.

4. British Thoracic Society. BTS/SIGN British Guidelines on the Management of Asthma (2016). www.brit-thoracic.org.uk/standards-of-care/guidelines/btssign-british-guideline-on-the-management-of-asthma.

5. Pavord, I. D. et al. The impact of poor asthma control among patients treated with inhaled corticosteroids plus long-acting β2 agonists in the United Kingdom: a cross-sectional analysis. npj Prim. Care Respir. Med. 27, 17 (2017).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3